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Osteoarthritis is the most common joint disease diagnosed in veterinary medicine and poses 
considerable challenges to canine welfare. This study aimed to investigate prevalence, duration 
and risk factors of appendicular osteoarthritis in dogs under primary veterinary care in the UK. The 
VetCompassTM programme collects clinical data on dogs attending UK primary-care veterinary 
practices. The study included all VetCompassTM dogs under veterinary care during 2013. Candidate 
osteoarthritis cases were identified using multiple search strategies. A random subset was manually 
evaluated against a case definition. Of 455,557 study dogs, 16,437 candidate osteoarthritis cases 
were identified; 6104 (37%) were manually checked and 4196 (69% of sample) were confirmed as 
cases. Additional data on demography, clinical signs, duration and management were extracted for 
confirmed cases. Estimated annual period prevalence (accounting for subsampling) of appendicular 
osteoarthritis was 2.5% (CI95: 2.4–2.5%) equating to around 200,000 UK affected dogs annually. Risk 
factors associated with osteoarthritis diagnosis included breed (e.g. Labrador, Golden Retriever), being 
insured, being neutered, of higher bodyweight and being older than eight years. Duration calculation 
trials suggest osteoarthritis affects 11.4% of affected individuals’ lifespan, providing further evidence 
for substantial impact of osteoarthritis on canine welfare at the individual and population level.
Osteoarthritis is the most commonly diagnosed joint disease in both human and veterinary medicine1,2 
Osteoarthritis is typically characterised by progressive degeneration and remodelling of synovial joints, leading 
to impaired mechanical function of the joint and pain3. In humans, osteoarthritis can be an extremely painful 
and sometimes a debilitating chronic condition that may result from systemic and local biomechanical factors, or 
develop post-trauma2. Apparent gait disturbances and positive response to analgesic therapy in dogs could well 
reflect similar pain experienced by affected dogs4.
Osteoarthritis is usually described as a multifactorial disease with a strong genetic component and can be 
exacerbated by aspects of lifestyle individual to each dog, including diet and exercise levels5. In the dog, osteo-
arthritis is often described as secondary, whereby a prior primary joint abnormality such as cruciate ligament 
rupture or patellar luxation is thought to incite the subsequent development of osteoarthritis3. Currently, it is 
unknown what proportion of dogs develop osteoarthritis secondary to these or other specific predisposing 
conditions6.
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The prevalence of osteoarthritis in dogs is reported in the literature with conflicting values. Estimates 
have ranged from 6.6% based on primary-care data7 to 20% based on referral data4 in the UK dog population. 
Estimates from North America report age specific prevalence values ranging from 20% in dogs older than one 
year up to 80% in dogs older than eight years, based on radiographic and clinical data from referral settings8.
While it can develop at any age, osteoarthritis is commonly considered a disease of aging and the most com-
monly reported sites affected by osteoarthritis in the dog include the stifles, hips and elbows4. It is generally later 
in a dog’s life that osteoarthritis becomes a more significant problem and thus the disorder is typically diagnosed 
when mobility is substantially affected6. It is suggested that more than 50% of diagnosed dogs are aged from 8 to 
13 years1. The length of time that dogs are affected by osteoarthritis is not well reported in the published literature 
because of difficulty in pinpointing the precise onset of the disease and limited availability of long-term cohort 
clinical data on confirmed cases. Although osteoarthritis may begin at any age, it may not be clinically diagnosed 
until it reaches a more advanced stage with obvious external clinical signs4. In addition, while joint degeneration 
may already be present when the initiating cause is diagnosed, it may not yet be recorded or coded as osteoarthri-
tis in the clinical notes at this point. Longitudinal studies have reported that osteoarthritis can affect a substantial 
proportion of lifespan in some affected dogs9.
Several risk factors have been reported for osteoarthritis, suggesting that certain systemic and local factors 
(animal level factors such as breed, age, sex and obesity) can considerably affect the development of osteoarthritis. 
Males are frequently discussed as predisposed to osteoarthritis more so than females10. This could be due to sex 
hormone or activity differences as well as differences in bodyweight between males and females10. Previous stud-
ies have reported that neutered dogs are more likely to develop joint diseases11. It is suggested that this association 
is due to the reduction in gonadal hormones which act as protectors against osteoarthritis11, or due to the positive 
association of neutering with weight gain, whereby higher bodyweight is linked with increasing osteoarthritis 
development12.
Insurance status has been reported to positively affect diagnosis in other joint diseases13. For osteoarthritis, 
this effect is likely due to the cost consideration of diagnostic imaging being removed when dogs are insured and 
the subsequent increased confidence of diagnosis when supported with radiographic evidence.
Many breed types are reported to be predisposed to developing osteoarthritis, particularly larger breeds, 
which have higher bodyweights7, and purebreds have been considered to be at increased risk of developing oste-
oarthritis potentially linked to the inherited defects related to conformation of certain breeds14.
Finally, the effect of obesity on developing osteoarthritis has been highlighted in previous work. Studies con-
ducted on Labrador retriever litters demonstrated the impact of disease development between dogs fed ad libi-
tum compared with a controlled intake diet, which highlighted that dogs fed ad lib (and therefore more likely to 
become overweight), were more likely to develop osteoarthritis9.
Study Aims
The aims of this study were (i) to estimate the prevalence of osteoarthritis in the UK dog population; (ii) to 
identify risk factors for osteoarthritis; (iii) to explore methods of using electronic patient record (EPR) data from 
veterinary patients, to calculate/reflect the length of time individuals are affected with osteoarthritis, in order to 
estimate mean durations of osteoarthritis in affected animals and to suggest potentially useful methods for future 
studies and (iv) to describe how osteoarthritis cases are diagnosed and managed in clinical practice. Aims i and 
ii will be addressed by testing the following hypotheses: (i) prevalence of osteoarthritis lies between 6% and 20% 
in the UK dog population; (ii) insured status, older dogs, male dogs, neutered dogs, heavier dogs and purebred 
dogs are risk groups with increased odds of osteoarthritis diagnosis. Aims (iii) and (iv) will be answered using 
descriptive analysis of clinical data extracted from manually reviewed EPRs.
Methods
Study design. Materials. The study used data collected within The VetCompassTM Animal Surveillance 
programme. VetCompassTM collates de-identified EPR data from primary-care veterinary practices in the UK 
for epidemiological research7. Practices volunteered to participate in the project and to allow extraction of their 
clinical data from within appropriately configured practice management systems. Information collected included 
patient demographic (species, breed, date of birth, sex, neuter status, insurance status and bodyweight at various 
time points) and clinical information. Practitioners could record summary diagnosis terms from an embedded 
VeNom Code list (a standard set of clinical veterinary terms) during episodes of care. Free-form text clinical 
notes, treatment and deceased status with relevant dates were also available. EPR data were extracted from prac-
tice management systems using integrated clinical queries15 and uploaded to a secure VetCompassTM structured 
query language (SQL) database.
Availability of materials and data. The datasets generated and analysed during the current study are not 
publicly available due to their use in ongoing primary research but subsections may be made available from the 
corresponding author on reasonable request.
Database search. Pilot Study. Initial pilot investigations were conducted to refine a range of search terms 
used to identify candidate cases within the denominator population. Terms were tested multiple times and 
refined to accommodate spelling variations and mistakes. A case definition for appendicular osteoarthritis that 
was applicable to the information available in the EPRs was constructed that aimed to minimise the number of 
false negative and false positive cases identified. Because many osteoarthritis cases may not undergo diagnostic 
imaging procedures in primary-care practice, the case definition needed to be broad enough to include common 
diagnostic protocols typically used in primary-care veterinary practice to diagnose osteoarthritis cases, including 
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combinations of anamnesis, clinical examination, advanced imaging, cytology and other laboratory methods, and 
trial therapy. A list of data to be extracted on cases to obtain detailed information related to the patient, diagnosis, 
treatments and behaviour was trialled and created based on availability of data with the EPRs (see Supplementary 
Note 1 for full list of questions).
An osteoarthritis case was defined as any dog with strong evidence for appendicular skeletal osteoarthri-
tis recorded in the EPR, this included: a final recorded diagnosis or insurance claim for osteoarthritis (or syn-
onym) or that had typical clinical signs and was clinically managed for osteoarthritis e.g. rest, non-steroidal 
anti-inflammatory drugs (NSAIDs) and supplements (or synonym) or where imaging findings were recorded 
that were typical of osteoarthritis (e.g. osteophytosis, enthesiopathy, new bone formation, subcondral sclerosis, 
Morgan’s line).
Exclusion criteria as part of the case definition included:
 i. osteoarthritis, degenerative joint disease (DJD) or synonym was only listed as one of a differential list.
 ii. an earlier diagnosis of osteoarthritis, DJD or synonym was later revised to exclude osteoarthritis in the 
clinical notes.
 iii. diagnosed only with immune mediated, auto-immune, rheumatoid and septic arthritis/polyarthritis.
 iv. osteoarthritis diagnosis related only to non-appendicular locations.
Main Study. Candidate case finding used searches conducted on the database to identify potential osteoarthritis 
cases within a one-year sampling time frame from 1 January 2013 to 31 December 2013. Search terms used were 
not case-sensitive and covered the clinical notes (osteoa*, OA, degen* + joint*, joint dise*, DJD, osteoph*, arth*) 
and treatments (cartrophen ~ 2, seraquin, Hill JD, yumove, “mobility treats”, cosequin, Green lipped (mussel), 
ArthriAid, adequan, specific canine cjd, joint support, chondroitin).
Case confirmation involved manual review of a random subset of EPRs of candidate osteoarthritis cases to 
discriminate whether the EPR contained sufficient evidence to meet the case definition criteria during 2013. 
Confirmed cases also included dogs where the records showed continuation of treatment or insurance claims 
from a pre-existing diagnosis before 2013 (thus including cases both incident (first diagnosed in 2013) and 
pre-existing (diagnosed pre-2013) in that year). Time constraints precluded extracting detailed data, from the 
piloted questions, on every case, and therefore every third confirmed case underwent further data extraction to 
provide a relevant sample size (Supplementary Note 1).
Analysis. Relevant records were exported from the VetCompass database to a Microsoft Excel (2016) work-
sheet for data cleaning and analysis. Descriptive analysis was conducted within Excel for estimation of duration 
metrics.
The study design used cohort clinical data to classify each animal as either a case or a non-case for osteoar-
thritis during the study period. Overall, 455,557 dogs were included in the study as a denominator population 
(Table 1), each qualifying for inclusion by the presence of at least one EPR (clinical note, bodyweight or treat-
ment) either during 2013, or at least one EPR both before and after 2013.
The prevalence estimate was calculated using cross-sectional analysis (accounting for subsampling) from 
dogs that had osteoarthritis during the study period (2013) and included both incident and pre-existing cases. 
Prevalence was calculated using the following method: 68.8% of the candidate cases randomly reviewed were 








Number of individuals 455,557 16,437 4196






Male 234, 212 (51.4%) 8,698 (52.9%) 2,261 (53.9%)
Female 219,033 (48.1%) 7,715 (46.9%) 1,929 (46.0%)
Unrecorded: 2,312 (0.5%) 24 (0.1%) 6 (0.1%)
Insurance Status
Insured 31,737 (7.0%) 2,981 (18.1%) 734 (17.5%)
Uninsured 26,029 (5.7%) 1,225 (7.5%) 335 (8.0%)
Unrecorded 397,791 (87.3%) 12,232 (74.4%) 3,127 (74.5%)
Neuter Status
Neutered 205,020 (45.0%) 9,405 (57.2%) 2,486 (59.2%)
Entire 178,218 (39.1%) 3,266 (19.9%) 794 (18.9%)
Unrecorded 72,319 (15.9%) 3,766 (22.9) 916 (21.8%)
Purebred Status
Purebred 340,769 (74.8%) 12,579 (76.5%) 3,234 (77.1%)
Crossbred 98,931 (21.7%) 3,568 (21.7%) 953 (22.7%)
Unrecorded 15,857 (3.5%) 290 (1.8%) 9 (0.2%)
Table 1. Population characteristics for the denominator population and candidate population attending 
primary care practices in the UK.
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Four alternative approaches to reflect duration/temporal length of osteoarthritis effect in individual cases were 
trialled. Each method made a core assumption that the condition was permanently present following the point of 
initial diagnosis, even if the condition was successfully clinically managed.
 (1) Period from date of diagnosis to date of final electronic patient record (for both cases with no recorded 
death and recorded death)
 (2) Period from date of diagnosis to date of coding in this study (1/10/2016) (up to date records were available 
for all cases and therefore those with no recorded death and a final record date before the coding in this 
study will still have osteoarthritis when coding commenced, as it is incurable)
 (3) Period from date of first diagnosis to date of death (if death recorded)
 (4) Percentage of lifespan affected, in cases with recorded death during the study period, i.e. [(date of death - 
diagnosis date)/age at death].
Median values were calculated for each duration parameter and presented separately for comparison. In addi-
tion, the age distribution of cases at diagnosis was determined as a potential indicator of the common age/stage of 
life at apparent onset of osteoarthritis. Comparison between the age distribution of the denominator population 
(as of 31st Dec 2013) and age at diagnosis of cases was undertaken. Finally, within Excel, the types of management/
treatment of osteoarthritis cases was analysed using descriptive statistics and percentages were calculated for each 
types of management and treatment methods.
Statistical Analysis. The age subset data was skewed when tested for normality, therefore a non-parametric 
Mann-Whitney test was used to test for a statistically significant difference between the median age of the case 
population (age at diagnosis) against the age of the denominator population (age as of July 1st 2013 for dogs born 
before this date and the age at December 31st otherwise).
Sample size calculations using Epi Info 7, showed 406 cases and 10,146 non-cases would have 80% power to 
detect a risk factor with an odds ratio of 1.5 or more (2-sided confidence interval 95%) with a 10% prevalence of 
osteoarthritis in the unexposed sample. Cross-sectional risk analysis was conducted using SPSS v22 on confirmed 
cases (both incident and pre-existing) and non-cases (non-cases were defined as all dogs in the denominator 
population excluding candidates), using both univariable and multivariable binary logistic regression modelling 
to evaluate the associations of breed, sex, age, Kennel Club (KC) breed group, bodyweight relative to breed, adult 
bodyweight, insurance, purebred and neuter status with a recorded diagnosis of osteoarthritis. A ‘breed type’ 
variable included individual breeds with 10 or more osteoarthritis cases, and a general grouping of crossbred as 
the comparison group. A ‘purebred’ variable categorised all dogs with a recognisable breed name as ‘purebred’, 
and the remaining dogs as ‘crossbred’. A ‘Kennel Club breed group’ variable categorised breeds grouped accord-
ing to the relevant UK Kennel Club breed groups (gundog, hound, pastoral, terrier, toy, utility and working). 
‘Adult bodyweight’ described the maximum bodyweight recorded during the study period for dogs older than 
18 months and was categorised into six groups (0.0–9.9 kg, 10.0–19.9 kg, 20.0–29.9 kg, 30.0–39.9 kg, ≥40.0 kg 
and unrecorded (including dogs <18 months)). A ‘bodyweight relative to breed’ variable categorised dogs >18 
months based on their weight compared to the mean weight calculated for their breed and sex into ‘under the 
given mean average’, ‘at/over the mean average’ or ‘unrecorded’. Neuter status described the neutering status of 
the dog (‘neutered’ or ‘entire’) at the final EPR available. Insurance status (‘insured’ or ‘uninsured’) described 
whether a dog was insured at any point covered by their available EPR. The age variable described the age (years) 
at the date of first recorded diagnosis of osteoarthritis for confirmed cases. Pre-existing cases were counted as ‘not 
recorded’. For non-cases this variable described the age on July 1st, 2013 for dogs born before this date and the 
age at December 31st otherwise. Age was entered as a 6-group categorical variable (<3.0 years, 3.0–5.9, 6.0–8.9, 
9.0–11.9, ≥12.0, not recorded).
Binary logistic regression modelling was used to evaluate univariable associations between potential risk fac-
tors (purebred status, breed type, bodyweight relative to breed, age, sex, KC breed group, neuter and insurance 
status, adult bodyweight) and a recorded diagnosis of osteoarthritis. Both pre-existing and incident osteoarthritis 
cases were included. Liberally associated variables (p < 0.20) were carried forward into multivariable modelling. 
A multivariable model was run excluding purebred and KC breed group (because these were directly co-linear to 
breed type, as breed type was a main interest variable). Adult bodyweight was also excluded from multivariable 
model as this is a defining characteristic of individual breeds [method adapted from16]. Univariable analysis was 
used to interpret these variables. Variables included in the multivariable model were: breed type, sex, neuter, 
insurance status, bodyweight relative to breed mean and age). Model development used an automated backwards 
elimination (Wald) model in order to remove the least significant variables from the final step model (p < 0.05). 
Pairwise interactions were tested for all variables in the final multiple model, to explore potential interactions 
between terms not previously investigated. Biological relevance was considered for pair-wise interactions before 
putting them into the final model. Statistical significance was set at p < 0.05. The area under the ROC curve was 
used to evaluate the quality of the model fit.
Ethics approval. Ethical approval was granted by the College of Science’s Ethics Committee at the University 
of Lincoln, UK in May 2016 (Reference number CoSREC125).
Results
Study Population. The study included 455,557 dogs. Following the initial input of relevant search terms, 
16,437 candidate osteoarthritis cases were identified. Of these, 6102 (37.1%) were manually reviewed in detail 
and 4196 of these candidate cases (68.8%) were confirmed as osteoarthritis cases, with 1259 (30.0% of the 4196 
cases) undergoing full data extraction.
www.nature.com/scientificreports/
5Scientific RePORTS |  (2018) 8:5641  | DOI:10.1038/s41598-018-23940-z
Prevalence estimate. The estimated annual period prevalence of osteoarthritis diagnosis in dogs under pri-
mary veterinary care in the UK during 2013 was 2.5% (CI95: 2.4–2.5%). Prevalence of the most frequently affected 
breeds was also calculated with the most prevalent breeds being large breeds, specifically: Golden Retriever (7.7% 
of all Golden retrievers), Labrador Retriever (6.1% of all Labradors), Rottweiler (5.4% of all Rottweilers) and 
German Shepherd Dog (4.9% of all German Shepherds) (Table 2).
Duration estimate. Median values for proposed osteoarthritis duration indicators/measures were as follows 
(time in years; interquartile range (IQR); number of dogs contributing to measure):
 (1) Time from date of diagnosis to date of final record (1.0 years; IQR = 2.0 years; n = 1146)
 (2) Time from date of diagnosis to date of coding in this study (1.0 years; IQR = 1.0 years; n = 860)
 (3) Date of first diagnosis to date of death (3.0 years; IQR = 2.0 years; n = 384)
Mean percentage of lifespan affected was 11.4% (CI95: 10.0–12.9%), based on 384 cases with recorded date of 
diagnosis and death.
Age at Diagnosis. Median age at first diagnosis of osteoarthritis was 10.5 years (IQR = 5.0; lower quartile 
6.0, upper quartile 11.0), which differed significantly (p < 0.001) from the median age of the overall denominator 
population in 2013 at 4.1 years (IQR = 5.9 lower quartile 1.7, upper quartile 7.6).
Clinical management. Eighty-five percent of osteoarthritis cases were managed with at least one clinical 
modality (medical or surgical treatments) following osteoarthritis diagnosis. Seventy-five percent of cases were 
recommended an analgesic, of which 77.9% actually received an analgesic drug. Non-steroidal anti-inflammatory 
drugs (NSAIDs) were the most frequently used analgesic drug group. Surgical interventions were implemented 
in 4.8% of cases and 4.6% were referred for further treatment and/or investigations overall. Weight loss was rec-
ommended in 25.5% and exercise restriction was recommended in 18.8% of cases. At the final available record, 
74.3% of cases remained on medical treatment.
Risk analysis. Univariable binary logistic regression modelling showed all factors (insurance status, age, sex, 
bodyweight relative to breed, adult bodyweight, neuter status, purebred status and UK Kennel Club breed group 
and breed-type) were associated with diagnosis of osteoarthritis (p < 0.20) (Tables 3 and 4) and were subsequently 
included in various multivariable binary logistic regression model building.
In the univariable analysis for purebred status, purebred dogs were significantly more likely to have a diag-
nosis of osteoarthritis than crossbreed dogs (p < 0.001, Purebred OR 1.1 CI95 1.0 to 1.2). KC breed type was 
significantly associated with osteoarthritis diagnosis (p < 0.001,), with the Gundog, Pastoral and Working breed 
groups all statistically more likely to receive a diagnosis of osteoarthritis compared to crossbreeds (Table 3). Adult 
bodyweight was statistically significant (p < 0.001) and showed the odds ratios increased with bodyweight with 
the >40 kg category having the greatest odds of having an osteoarthritis diagnosis (OR 11.3 CI95 11.0 to 12.8).
The final model showed good discrimination (area under the ROC curve: 0.856). In the final multivaria-
ble model (Table 5), eleven breeds (Border Collie, Bull Mastiff, Dogue de Bordeaux, German Pointer, German 
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Golden Retriever 7.74 7.06 8.48 156 421 5439
Labrador 6.13 5.88 6.39 753 2043 33321
Rottweiler 5.43 4.85 6.07 107 289 5321
German Shepherd 4.93 4.56 5.33 224 602 12204
Border Collie 4.52 4.17 4.91 205 554 12264
English Springer 3.36 2.91 3.88 67 181 5384
Springer Spaniel 3.26 2.83 3.75 70 189 5800
Boxer 2.89 2.49 3.32 67 181 6283
Crossbreds 2.60 2.50 2.70 953 2575 98931
West Highland Terrier 2.54 2.27 2.84 113 305 12017
Cavalier King Charles 2.42 2.14 2.74 91 245 10143
Staffordshire Bull terrier 2.22 2.06 2.39 248 673 30275
Yorkshire Terrier 1.23 1.07 1.42 70 189 15426
Cocker Spaniel 0.54 0.48 0.61 95 257 47481
Jack Russel 0.39 0.36 0.45 122 330 82777
Table 2. Estimated one year period prevalence of osteoarthritis by breed for the most frequent breeds (over 50 
individuals) as recorded in primary care practice in the UK during 2013.
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Springer Spaniel) had higher odds of osteoarthritis diagnosis than crossbreeds, with the Rottweiler (OR 3.1, CI95 
2.5 to 3.8), Dogue de Bordeaux (OR 2.8, CI95 1.7 to 4.7) and Old English Sheepdog (OR 2.8, CI95 1.6 to 5.0) hav-
ing the greatest odds ratio. Nine breeds had a statistically decreased association with an osteoarthritis diagnosis 
compared to crossbreeds. Insured individuals had 2.0 times the odds compared to non-insured dogs (OR CI95 
1.8 to 2.3). Neutered individuals had 1.8 (CI95 1.7 to 2.0) times the odds of diagnosis compared with entire dogs. 
Males had an odds ratio of 1.2 (OR CI95 1.1 to 1.3) compared to females. The odds of osteoarthritis increased with 
increasing age (p < 0.001). Bodyweight relative to breed mean was also significant in the final model (p < 0.001), 
with the model indicating that dogs that were at or over average weight had increased odds ratio for having a 
diagnosis of osteoarthritis compared to dogs that were under the average weight for their breed and sex (OR 2.3, 
CI95 2.1–2.4).
Discussion
In this study, annual period prevalence was calculated at 2.5% from a population of 455,557 dogs attending 
primary-care practices. This prevalence estimate of 2.5% is significantly lower than the previous estimates7 and4 
which ranged from 6.6%7 to 20%8. Whilst the 6.6% estimate was also primary-care data, the dataset was smaller 
than this current study (sample population of 148,741), the time frame was much greater and that study did not 
use as tight a case definition as this study7. Other prevalence estimates have been suggested to be as high as 20% 
prevalence in dogs over one year of age, however this is based on the North American referral dog population 




Insured 1.86 1.63 2.14 <0.001
Age <0.001
<3 years Base
3–5.9 years 4.18 3.40 5.15 <0.001
6–8.9 years 15.75 13.01 19.06 <0.001
9–11.9 years 35.92 29.77 43.36 <0.001
>12 years 58.03 48.11 69.99 <0.001
Sex <0.001
Female Base
Male 1.10 1.03 1.17 0.005
Bodyweight relative to breed mean <0.001
Under Base
At or Over 2.30 2.15 2.45 <0.001
Adult Bodyweight (kg) >18 months
<10.0 Base
10.0–19.9 2.84 2.51 3.20 <0.001
20.0–29.9 5.10 4.53 5.73 <0.001
30.0–39.9 8.28 7.37 9.30 <0.001
>40 11.28 10.98 12.76 <0.001
Unrecorded 1.36 1.14 1.62 0.001
Neuter Status <0.001
Entire Base
Neutered 2.68 2.47 2.92 <0.001
Purebred status <0.001
Crossbreed Base
Purebred 1.07 0.99 1.15 0.072
Kennel Club Breed Group <0.001
Crossbreed Base
Gundog 2.28 2.10 2.47 <0.001
Pastoral 2.36 2.13 2.62 <0.001
Hound 0.77 0.62 0.95 0.014
Utility 0.55 0.47 0.64 <0.001
Terrier 1.06 0.95 1.17 0.320
Toy 0.49 0.43 0.57 <0.001
Working 1.49 1.30 1.71 <0.001
Table 3. Univariable logistic regression results for risk factors associated with osteoarthritis diagnosis in dogs 
attending primary-care veterinary practices in the UK.
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from 19978. The methodology of the North American study used radiographic diagnoses as cases, as structural 
changes due to osteoarthritis can be confirmed8. However, another study showed that radiographic evidence of 
osteoarthritis correlates poorly with clinical limb function of dogs with osteoarthritis, which highlights a lim-
itation of a radiographic only diagnosis study17. The use of primary-care data has been suggested to be more 
representative of the general dog population, as referral populations are sub-selected based on the severity and 
complexity of the cases and inherently lead to bias18. The majority of referral populations tend to have at least one 
illness to justify referral, whereas many animals in primary-care populations have no illnesses and instead pres-
ent for routine or prophylactic reasons7. This may have the effect of making referral populations have apparently 
higher prevalence values compared with primary-care populations, especially for severe or complicated disorders 
that are more likely to get referred19.
It should be noted that our study may give a conservative prevalence estimate due to the nature of data acqui-
sition. A tight case definition was designed to increase the specificity of the study; however, some true cases may 
have been excluded due to insufficient information available in the EPR. Additionally, primary-care data relies 
heavily on the input from the veterinarian treating the individual, resulting in differing examination, diagnostic 




Shih-tzu 0.28 0.20 0.38 <0.001
Labradoodle 0.36 0.20 0.66 0.001
Beagle 0.38 0.22 0.66 0.001
Husky 0.39 0.24 0.64 <0.001
Miniature Schnauzer 0.42 0.26 0.70 0.001
Bichon 0.45 0.31 0.65 <0.001
Jack Russell 0.46 0.38 0.55 <0.001
Yorkshire Terrier 0.46 0.36 0.59 <0.001
British Bulldog 0.49 0.30 0.80 0.004
Lhasa Apso 0.49 0.35 0.70 <0.001
Border Terrier 0.51 0.35 0.74 0.001
Cocker Spaniel 0.61 0.45 0.76 <0.001
Akita 0.74 0.47 1.24 0.256
Lurcher 0.74 0.49 1.12 0.156
King Charles Spaniel 0.81 0.643 1.02 0.073
Staffordshire Bull Terrier 0.82 0.72 0.95 0.006
Basset Hound 0.83 0.44 1.55 0.552
Dogue de Bordeaux 0.83 0.50 1.39 0.483
Bull Mastiff 0.93 0.54 1.62 0.803
West Highland Terrier 0.98 0.81 1.19 0.837
English Bull Terrier 1.01 0.58 1.75 0.981
Weimaraner 1.06 0.65 1.75 0.811
Boxer 1.12 0.87 1.43 0.384
Doberman 1.13 0.70 1.83 0.617
Springer Spaniel 1.30 1.09 1.56 0.004
Hungarian Vizsla 1.35 0.72 2.52 0.354
Greyhound 1.37 0.99 1.88 0.055
Cairn Terrier 1.45 0.94 2.25 0.093
Dalmatian 1.45 0.96 2.17 0.077
Border Collie 1.78 1.53 2.07 <0.001
Shetland Sheepdog 1.83 1.05 3.17 0.032
German Pointer 1.85 1.18 2.89 0.007
German Shepherd 1.98 1.72 2.29 <0.001
Rottweiler 2.17 1.77 2.65 <0.001
Scottish Collie 2.45 1.49 4.04 <0.001
Labrador Retriever 2.47 2.25 2.72 <0.001
Old English Sheepdog 3.05 1.75 5.31 <0.001
Golden Retriever 3.22 2.72 3.81 <0.001
Table 4. Univariable logistic regression results for breed type associated with osteoarthritis diagnosis in dogs 
attending primary-care veterinary practices in the UK.
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and note-taking preferences. Some true osteoarthritis cases may not have been included due to lack of follow 
up or because osteoarthritis was listed only as one of a list of differential diagnoses, along with other primary 
joint-diseases, such as dysplasia. Irrespective of likely under-estimation, based on an estimated UK dog pop-
ulation of 8.5 million dogs (2017 Pet Food Manufacturers’ Association), the prevalence figure suggests at least 
200,000 dogs are affected by osteoarthritis annually in the UK and therefore still provides substantial evidence for 
major welfare impact at a UK population level. In terms of welfare, the actual prevalence of ‘joint disease’ will be 
significantly higher, than this osteoarthritis prevalence would imply.
Four calculation methods were trialled in this study as exploratory methods to estimate disease duration. The 
most definitive of these calculations were the date of first diagnosis to date of death and the subsequent calcula-
tion of percentage of life span from these same numbers. These are the safest data as they give the latest value of 
the true start and end dates; however, the data were limited to only the dogs that died during the case of the study 
which, in the case of this study, was 384. The other two calculations were limited by data availability but had larger 
sample sizes; however, these do not reflect the duration as well, as they use estimated end dates or incomplete 
end dates and so the figures may be inaccurate and duration may actually be much greater when death is actually 
Independent Variable Numbers in population Odds Ratio 95% CI Significance
Case Non-case Lower Upper
Insurance Status <0.001
Uninsured 304 20,745 Base
Insured 651 23,801 2.02 1.76 2.33 <0.001
Age <0.001
<3 years 120 136,217 Base
3 to 5.9 years 348 94,496 3.55 2.88 4.37 <0.001
6 to 8.9 years 872 62,864 12.58 10.37 15.25 <0.001
9 to 11.9 years 1191 37,634 28.83 23.84 34.86 <0.001
>12 years 1306 25,548 53.89 44.57 65.15 <0.001
Sex <0.001
Female 1772 174,167 Base
Male 2068 185,628 1.19 1.11 1.27 <0.001
Neuter Status <0.001
Entire 717 139,212 Base
Neutered 2303 166,682 1.80 1.65 2.00 <0.001
Breed <0.001
Crossbreed 953 95,363 Base
Rottweiler 107 4940 3.11 2.53 3.83 <0.001
Old English Sheepdog 13 427 2.81 1.59 4.98 <0.001
Dogue de Bordeaux 15 1803 2.81 1.67 4.73 <0.001
Labrador Retriever 758 30,679 2.56 2.31 2.82 <0.001
Golden Retriever 163 5071 2.42 2.03 2.88 <0.001
German Shepherd 231 11,656 2.28 1.96 2.64 <0.001
Bull Mastiff 13 1395 1.82 1.04 3.17 0.035
Scottish Collie 16 654 1.77 1.06 2.94 0.029
German Pointer 20 1081 1.62 1.03 2.55 0.038
Border Collie 205 11,551 1.51 1.29 1.76 <0.001
Springer Spaniel 138 10,616 1.25 1.05 1.51 0.015
Cocker Spaniel 95 15,477 0.70 0.57 0.87 0.001
West Highland Terrier 113 11,543 0.66 0.54 0.81 <0.001
Bichon 29 6484 0.62 0.42 0.89 0.011
Lhasa Apso 33 6720 0.58 0.41 0.83 0.003
Miniature Schnauzer 16 3780 0.55 0.33 0.90 0.017
Border Terrier 27 5334 0.53 0.36 0.78 0.001
Shih-tzu 41 14,873 0.47 0.34 0.64 <0.001
Jack Russell 124 27,119 0.41 0.34 0.50 <0.001
Yorkshire Terrier 70 15,114 0.40 0.31 0.51 <0.001
Bodyweight relative to breed average mean <0.001
Under 1426 178,081 Base <0.001
At or Over 2535 137,748 2.29 2.14 2.44
Table 5. Results of multivariable binary logistic regression for risk factors associated with diagnosis of 
osteoarthritis in dogs attending primary-care practices in the UK.
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reached. In order to report duration more accurately, duration studies with full cohort analysis using reliable date 
points from thousands of individuals (birth date-diagnosis date-death date) would provide the most accurate 
representation of disease duration in diseases that are permanent. However, where this is not available, date of 
diagnosis to date of death provides the most valuable tool for assessing duration, even if the sample is relatively 
small. In the current study, the percentage of life affected by osteoarthritis was reported as 11% based on the 
sub-set of cases with recorded death in available EPRs. Many osteoarthritis cases may well be diagnosed later in 
life, but earlier signs may be missed or still considered normal to the owner and may only become apparent when 
the animal ages or when debility reaches more noticeable levels. Therefore, many more dogs could be suffering for 
a longer duration than what is recorded in EPRs, with implications for welfare20.
Crossbreeds are often considered to have health benefits from hybrid vigour because of reduced homozygo-
sity21. In this study, purebreds showed slightly increased odds ratio (1.1) for osteoarthritis compared to cross-
breeds, with the increased risk of developing osteoarthritis potentially linked to the inherited defects related to 
conformation in particular breeds14. However, other studies have also shown that crossbreeds may be more prone 
than purebreds to joint disorders such as cruciate ligament rupture, that can lead to osteoarthritis development22. 
This increase in crossbreeds, could be due to individuals that genetically aren’t suitable for purebred breeding, are 
used in breeding crossbreeds. It may be the case that the parent breeds of crossbreds include at risk breeds (e.g. 
larger breeds or Labradors), and a genetically predisposed crossbred may also result, increasing their suscepti-
bility to disorders such as osteoarthritis, instead of creating the desired hybrid vigour that crossbreeding is often 
claimed to achieve21.
Eleven breeds had significantly higher diagnosis of osteoarthritis compared to crossbreed dogs in the current 
study. These included: Border Collie, Bull Mastiff, Dogue de Bordeaux, German Pointer, German Shepherd Dog, 
Golden Retriever, Labrador Retriever, Old English Sheepdog, Rottweiler, Scottish Collie and Springer Spaniel. 
These findings are consistent with previous studies7,23 and24. These are all medium/large breeds and therefore have 
high bodyweight. All of these breeds fall under the working, pastoral and gundog KC breed types, which were 
also found to have increased odds of developing OA. This could be similar to occupational osteoarthritis seen in 
humans as a result of increased physical workload on the joints25. The classification of a dog as being of, for exam-
ple, a ‘working’ breed group may however, bear very little relationship with how much ‘work’ or exercise the dog 
actually gets. True levels of ‘work’ or exercise that the dogs in this study received was not available, and therefore 
further studies to investigate this potential comparison with occupational osteoarthritis in humans would be ben-
eficial. Many smaller breeds in the current analysis (e.g. Yorkshire Terrier, West Highland Terrier and Shih-tzu) 
had statistically significantly reduced odds of an osteoarthritis diagnosis compared to crossbreeds. Smaller breeds 
may show less obvious lameness/apparent pain than larger breeds and therefore receive lower diagnostic propor-
tions than the breeds, with studies showing that lameness assessments are difficult due to gait differences26.
Previous research suggested that male dogs have greater odds of developing osteoarthritis than females10, and 
that neutered dogs have higher odds of developing cruciate ligament problems and hip and elbow dysplasia, with 
associated higher risk of secondary osteoarthritis13,27 and28. In the current study, males had 1.2 times the odds of 
osteoarthritis and neutered individuals had 1.8 times the odds. Neutering may reduce gonadal hormone protec-
tion of joints compared with entire individuals13,27,28. An association between neutering and weight gain has also 
been previously demonstrated29 and could explain part of the increase in neutered dogs. Neutering has also been 
shown to affect the satiety of individuals due to changes in hormones such as oestrogen29. Adult bodyweight was 
identified as a risk factor, with increasing odds of having an osteoarthritis diagnosis with increasing bodyweight, 
suggesting that dogs that are neutered and subsequently gain weight, may be more likely to develop osteoarthritis. 
It should be noted however, without also having morphometric data, (e.g. body condition), it is difficult to know 
whether bodyweight reflects body condition (e.g. obesity) or just simply stature/size. It could also be the case that 
dogs below breed average weight describe a smaller framed subset of the breed and that this may influence the 
risk of the development of osteoarthritis. This would be a valuable factor to follow up, especially in breeds where 
breed standards tend to favour larger individuals. It is also conceivable that increased weight gain could be sec-
ondary to the osteoarthritis development due to reduced energy expenditure when debilitated by osteoarthritis or 
when physical activity is reduced, and hence neuter status could have a different mode of influence. In individuals 
that truly are obese, the mechanism increasing the likelihood of developing osteoarthritis could be related to the 
levels of leptin (shown to be higher in overweight individuals) which have been shown to have a damaging effect 
on articular cartilage and thus increase the risk of osteoarthritis12.
The results from the current study indicated that age of diagnosis was most frequently eight years and over and 
study dogs over twelve years had the highest odds of osteoarthritis diagnosis compared to other age groups, sup-
porting studies that suggest osteoarthritis is a disease of aging30, similar effects have also been shown in humans2. 
While this finding could suggest that osteoarthritis is occurring more in older dogs and the associated morbidity 
is strongly related to increasing age, it may also indicate that osteoarthritis is generally only noticed and/or inves-
tigated to the stage of formal diagnosis later in life. In addition, osteoarthritis can present differently symptomat-
ically, for example from a seemingly unnoticeable altered gait or behaviour to severe limping or lameness4 and 
therefore may not necessarily be picked up by the owner until it has progressed to a certain severity4. It has also 
been shown that in many cases owners don’t often recognise problems or changes in their dog related to inherited 
defects, such as osteoarthritis. Due to normalisation of certain health traits, some owners do not perceive changes, 
for example altered gait, as problems, but consider them normal20 and therefore presentation of osteoarthritis 
cases for veterinary attention may be delayed until changes worsen and become more apparent to the owner.
Insurance status was a significant ‘risk factor’ for diagnosis with osteoarthritis, with insured individuals 
demonstrating twice the odds of osteoarthritis diagnosis compared with non-insured individuals. A similar pos-
itive association for diagnosis has also been reported for other diseases13. In the instance of osteoarthritis, diag-
nostic imaging methods for diagnosis confirmation as well as the long-term nature of the condition and therefore 
treatment and costs are likely to explain much of the increased diagnosis associated with insurance. It may be the 
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case that uninsured individuals are more likely to receive an uncertain diagnosis (i.e. the diagnosis was part of 
a differential diagnosis) and/or no follow up diagnosis in the EPRs due to the owner not presenting their dog to 
the vet for follow-up, meaning they are excluded as cases from the study according to the inclusion criteria. This 
scenario could suggest compromised welfare in these uninsured, osteoarthritis-affected dogs, through lack of 
appropriate treatment or monitoring.
In relation to clinical management of osteoarthritis, 85.1% of cases were managed with at least one treatment 
following diagnosis, 75.7% of which included the use of an analgesic drug. This highlights the 24.3% of cases that 
were not administered analgesics. It is impossible to determine if this relates to a veterinarian31, or owner pref-
erence, or indeed disease severity, however it may suggest a welfare concern for these dogs. Surgery was used in 
4.8% of cases, and 4.6% were referred for further investigation and/or treatments. The low surgical intervention 
following the diagnosis of osteoarthritis, may be due to the costs or risks relating to the surgery (particularly 
older dogs), joint unsuitability, or resulting implications for quality of life that can occur during rehabilitation 
and recovery, or simply due to the fact that surgery is not appropriate for many cases. Eighty percent of cases 
in this study were managed using an analgesic treatment, prescribed at the primary-care consultations, 97% of 
these were NSAIDs. Whilst continual long-term use of NSAIDs has been suggested to sufficiently alleviate oste-
oarthritis pain, protracted use can lead to complications and impact quality of life, through the development of 
gastrointestinal problems, or organ damage, such as kidney or liver32, as well as long term costs and thus owners 
may be wary of continual use.
Exercise restriction (defined as any recommendation to reduce or stop exercise for any duration) was recom-
mended in 21% of osteoarthritis cases. Osteoarthritis can significantly affect the gait of a dog, which in turn can 
impact unaffected joints and therefore increase the negative impact of the disease for that individual33. Exercise 
restriction can play an important role, preventing further damage to other joints until pain can be managed, for 
example by dietary management or analgesic methods33. Exercise is recommended to be restricted to small and 
frequent exercise but not stopped totally as this can be detrimental to the general health of the dog and joints 
themselves4. For an active species, however, exercise can be extremely important both physically and mentally34, 
so this finding suggests canine welfare sometimes is affected short-term through management (e.g. where osteo-
arthritis affects the biological need for exercise and activity as part of behaviour) in order to improve the welfare 
in the long-term.
Twenty-eight percent of cases were recommended to undergo weight loss. This demonstrates awareness that 
weight loss is beneficial for osteoarthritis35. The current study reports that dogs at or above mean breed bod-
yweight were 2.3 times more likely to have osteoarthritis than dogs below average weight. Therefore, this rec-
ommendation to undergo weight loss may support a correlation between excessive bodyweight/obesity and the 
development or severity of osteoarthritis. However, it could also suggest cases diagnosed with osteoarthritis may 
go on to gain weight, perhaps through reduced exercise. Reducing food intake may again reduce the quality of 
life in the dog, a species that is well known for being food motivated36. It has been shown that diet alterations and 
food restrictions can have an effect on the behaviour and wellbeing of dogs37, demonstrating further that man-
agement of osteoarthritis can have a large impact on canine welfare and specific interventions must be carefully 
considered to ensure they outweigh the implications of not implementing them.
Whilst there is great potential from analyses of large datasets such as this to better understand the welfare 
impact of a condition, the study had a number of limitations. Firstly, only dogs who were under veterinary care 
were included in this study and consequently the results may not be fully generalisable to the entire wider popu-
lation, some of which may rarely attend a veterinary surgery, or not be registered at all and thus underrepresented 
in this study. Although this study included a convenience sample of both independent and linked primary-care 
practices that extended across England, Wales, Scotland and Northern Ireland, the majority were linked within 
larger practice groups and therefore may not be fully representative of the overall practices in the UK. The data are 
only as reliable as the notes recorded by the veterinary teams and the information provided by the owners. This 
study required the veterinarians to make the diagnoses of osteoarthritis, as well as record appropriate data in the 
EPRs. It should be noted that there is no definitive way of knowing the date when osteoarthritis first developed, or 
progressed to osteoarthritis from a predisposed disease process. Therefore, there are possibilities that some dogs 
with osteoarthritis were not diagnosed at all or that some recorded were also misdiagnosed. However, overall, all 
Royal College of Veterinary Surgeons-registered veterinarians should be well-placed to make a clinical diagnosis 
of osteoarthritis in primary-care practice and hence this study is likely to present an accurate overall representa-
tion. The denominator population included all dogs that were under veterinary care at a VetCompassTM practice 
in 2013, whether presenting healthy (for preventative medicine consultations) or sick (for any reason).
Conclusion
This study reports an annual period prevalence estimate of 2.5% for appendicular osteoarthritis in the UK dog 
population. Based on UK dog population estimates of 8 million this equates to just over 200,000 individuals 
affected with osteoarthritis in a given year. It was also shown that diagnosis was usually made when dogs were 
older. In cases with available dates of diagnosis and death mean proportion of lifespan affected was 11%. Risk 
factors for osteoarthritis showed a diagnosis was more likely in older individuals, males, neutered dogs, in dogs 
with higher bodyweights and insured dogs. Nine statistically predisposed breeds were highlighted by the analysis, 
with Old English Sheepdogs, Rottweilers and Dogue de Bordeauxs having the highest odd ratios. Clinical man-
agement of osteoarthritis was implemented in 90% of cases with use of analgesics being the most frequently used 
therapeutic intervention.
Taken together, findings of this study suggest that osteoarthritis poses a notable challenge to canine welfare 
with respect to numbers of dogs affected and perceived requirement for veterinary therapy including frequent 
use of analgesia. The suggested breed predispositions, duration of effect and the scale of welfare impact at the UK 
population level would benefit from investigation in greater depth.
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